Email not displaying correctly? Click here to view it in your browser.
      Interactive course for advanced users – 29-30 October 2018


This information is intended only for healthcare professionals in Europe, the Middle East and Asia Pacific.

Vienna University Hospital, Austria
Therakos Mallinckrodt

Vienna General Hospital, Medical University of Vienna has more than 300 years of history behind it. The original "Home for the Poor and Invalid" has developed into one of the most modern and advanced hospitals in Europe.

With more than 30 University clinics and clinical institutes, the Vienna University Hospital guarantees extremely high standards and innovative technologies in all medical fields. Patient care, training and research have been established as inseparable and equal elements, people are always at the centre of Vienna University Hospital’s tasks and objectives.

Scientific Workshop
Primary goal:
Advance knowledge on GvHD treatment , promote peer to peer discussions
Intended for:
Specialists treating patients with GvHD already having some experience with Extracorporeal Photopheresis
Monday 29 October 2018
19.30  Dinner with The faculty
Ristorante Danieli
Himmelpfortgasse 3, 1010 Wien
Tuesday 30 October 2018
Imperial Riding School Renaissance Vienna Hotel
Ungargasse 60, 1030 Vienna
08.00  Brief Overview about ECP across several diseases and latest clinical updates
Prof R Knobler
08.45  Extracorporeal Photopheresis, Mechanism of Immunomodulation
Dr S Behlke
09.00  Acute GvHD what’s new – a brief review of new data and the place of ECP
Prof H Greinix

  • Patient selection for ECP treatment (organ involvement, potential co-medication)
  • When to start ECP
  • Treatment schedule
  • Response assessment
  • Co medication and steroid/immunosuppressant tapering
  • Case discussions

11.00  Coffee break
11.30  Chronic GvHD diagnosis and treatment – a brief review of
Prof H Greinix

  • Consensus recommended diagnostic and scoring systems
  • NIH recommendations – what does response means
  • Patient selection for ECP therapy based on organ involvement – Vienna Experiences in review
  • Treatment schedule
    • When to start and stop?
    • Response assessment including change of co medication especially steroid /immunosuppressant taper
  • Case discussions
14.30  Final remarks
Prof H Greinix & Prof R. Knobler
15.00  Transfers to the airport

Notes: A working lunch will be served in the meeting room. Hotel check out should be done early in the morning not to impact course agenda.
To register your interest please email:
Therakos Mallinckrodt
Professor Robert Knobler – Medical University of Vienna, Austria

Professor Dr. Robert Knobler graduated in Medicine, Dermatology and Venerology from the University of Vienna, Austria.

From 1983 to 1985 Professor Knobler was Visiting Scientist at Columbia University College of Physicians and Surgeons, New York, USA; in Dermatology, Microbiology and Molecular Biology and a lecturer at the Columbia University College from 1985 to the present day.

From June 1985 to October 2010 Professor Knobler was Director (and founder) of the Photopheresis Center at the Division of Special and Environmental Dermatology.

Professor Knobler was Director of the Laboratory of Cell Biology at the 2nd University Department of Dermatology since May 1991; President (and Founder) of the European Society for Extracorporeal Photochemotherapy from May 1992 to February 2000; Secretary of the European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force from February 2000 to November 2005; and was chairman of the EORTC Cutaneous Lymphoma Task Force for two consecutive terms. He is presentely member of the group's board and CLTF NDAC Liaison Officer of the same.

Therakos Mallinckrodt
Professor Doctor Hildegard Greinix

Hildegard T. Greinix graduated in Medicine from the Karl-Franzens-University in Graz and completed her fellowship in internal medicine, hematology and oncology at the University Hospital of Graz. During her postgraduate training H. Greinix worked as research fellow in experimental and clinical marrow transplantation within the "Transplantation Biology" program of Professor Rainer Storb at the Fred Hutchinson Cancer Research Center in Seattle USA.

From 1992 until 2014 H. Greinix was Head of the BMT Outpatient Clinic and Director of the research programs on transplant immunology at the Department of Internal Medicine at the Medical University of Vienna. Since January 2015 she is the Head of the Division of Hematology at the Medical University of Graz, Austria.

H. Greinix has been chairing the Austrian Group for Blood and Marrow Transplantation within the Austrian Society of Hematology and Oncology. She is also the Vice-Chair of the German/Austrian/Swiss Consensus Group on chronic GvHD and the Chair of the GvHD Subcommittee of the Complications and Quality of Life Working Party of the EBMT. H. Greinix was invited to participate actively in the NIH Consensus Development Project on chronic GvHD.

H. Greinix established the use of extracorporeal photopheresis (ECP) for treatment of patients with acute and chronic GvHD and has more than 250 publications in well-known peer-reviewed scientific journals in the field of allogeneic HCT focusing on GvHD, its pathogenesis, diagnosis, predictive biomarkers and treatment strategies including ECP. She has extensive experience in performing retrospective and prospective clinical studies in patients with GvHD and is a member of several international research advisory boards.

Therakos and Mallinckrodt